A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Dexcom Inc stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 629,526 shares of DXCM stock, worth $50.5 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
629,526
Previous 525,064 19.9%
Holding current value
$50.5 Million
Previous $59.5 Million 29.13%
% of portfolio
0.1%
Previous 0.14%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $6.69 Million - $12.1 Million
104,462 Added 19.9%
629,526 $42.2 Million
Q2 2024

Aug 08, 2024

SELL
$110.31 - $140.45 $6.98 Million - $8.89 Million
-63,273 Reduced 10.75%
525,064 $59.5 Million
Q1 2024

May 10, 2024

SELL
$114.22 - $140.1 $4.06 Million - $4.98 Million
-35,538 Reduced 5.7%
588,337 $81.6 Million
Q4 2023

Feb 09, 2024

SELL
$75.49 - $124.16 $3.55 Million - $5.84 Million
-47,067 Reduced 7.02%
623,875 $77.4 Million
Q3 2023

Nov 09, 2023

BUY
$86.06 - $137.93 $1.44 Million - $2.3 Million
16,708 Added 2.55%
670,942 $62.6 Million
Q2 2023

Aug 08, 2023

SELL
$112.47 - $130.98 $4.12 Million - $4.8 Million
-36,620 Reduced 5.3%
654,234 $84.1 Million
Q1 2023

May 10, 2023

SELL
$104.0 - $122.92 $2.04 Million - $2.41 Million
-19,581 Reduced 2.76%
690,854 $80.3 Million
Q4 2022

Feb 10, 2023

BUY
$84.98 - $122.67 $141,151 - $203,754
1,661 Added 0.23%
710,435 $80.4 Million
Q3 2022

Nov 10, 2022

BUY
$76.35 - $94.18 $661,649 - $816,163
8,666 Added 1.24%
708,774 $57.1 Million
Q2 2022

Aug 09, 2022

BUY
$67.99 - $132.89 $35.7 Million - $69.9 Million
525,629 Added 301.26%
700,108 $52.2 Million
Q1 2022

May 12, 2022

SELL
$94.08 - $130.2 $801,655 - $1.11 Million
-8,521 Reduced 4.66%
174,479 $89.3 Million
Q4 2021

Feb 09, 2022

SELL
$129.87 - $162.82 $4.48 Million - $5.61 Million
-34,466 Reduced 15.85%
183,000 $98.3 Million
Q3 2021

Nov 12, 2021

SELL
$106.71 - $143.18 $1.16 Million - $1.55 Million
-10,831 Reduced 4.74%
217,466 $119 Million
Q2 2021

Aug 12, 2021

SELL
$80.99 - $107.93 $1.83 Million - $2.44 Million
-22,649 Reduced 9.03%
228,297 $97.5 Million
Q1 2021

May 12, 2021

SELL
$84.79 - $104.74 $1.33 Million - $1.65 Million
-15,726 Reduced 5.9%
250,946 $90.2 Million
Q4 2020

Feb 12, 2021

BUY
$78.0 - $104.5 $2 Million - $2.68 Million
25,640 Added 10.64%
266,672 $98.6 Million
Q3 2020

Nov 12, 2020

SELL
$95.51 - $112.95 $1.1 Million - $1.3 Million
-11,504 Reduced 4.56%
241,032 $99.4 Million
Q2 2020

Sep 11, 2020

SELL
$62.68 - $105.34 $173 Million - $291 Million
-2,762,127 Reduced 91.62%
252,536 $102 Million
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $173 Million - $291 Million
2,759,014 Added 1079.22%
3,014,663 $102 Million
Q1 2020

May 13, 2020

SELL
$47.79 - $75.63 $66,762 - $105,655
-1,397 Reduced 0.54%
255,649 $68.8 Million
Q4 2019

Feb 14, 2020

SELL
$36.62 - $57.29 $238,359 - $372,900
-6,509 Reduced 2.47%
257,046 $56.2 Million
Q3 2019

Nov 12, 2019

SELL
$35.53 - $43.8 $533,660 - $657,876
-15,020 Reduced 5.39%
263,555 $39.1 Million
Q2 2019

Aug 07, 2019

BUY
$27.84 - $38.92 $422,527 - $590,688
15,177 Added 5.76%
278,575 $40.6 Million
Q1 2019

May 13, 2019

BUY
$28.07 - $38.18 $206,230 - $280,508
7,347 Added 2.87%
263,398 $31.2 Million
Q4 2018

Feb 12, 2019

BUY
$26.99 - $37.37 $1.66 Million - $2.3 Million
61,571 Added 31.66%
256,051 $30.7 Million
Q3 2018

Nov 13, 2018

SELL
$23.35 - $36.72 $213,419 - $335,620
-9,140 Reduced 4.49%
194,480 $27.8 Million
Q2 2018

Aug 10, 2018

SELL
$17.54 - $25.22 $249,769 - $359,132
-14,240 Reduced 6.54%
203,620 $19.3 Million
Q1 2018

May 11, 2018

SELL
$13.06 - $18.54 $134,518 - $190,962
-10,300 Reduced 4.51%
217,860 $16.2 Million
Q4 2017

Feb 09, 2018

SELL
$11.12 - $15.38 $1.91 Million - $2.65 Million
-172,021 Reduced 42.99%
228,160 $13.1 Million
Q3 2017

Nov 13, 2017

BUY
$11.36 - $18.98 $4.55 Million - $7.6 Million
400,181
400,181 $19.6 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.